fallopian tube cell collection device

Remora builds carbon capture systems for semi-trucks and locomotives, extracting and purifying CO₂ from their exhaust so it can be sold to industrial users. Founder and CEO Paul Gross describes how a CO₂ shortage inspired the company, how he assembled a team with the needed expertise, and why Remora is based near Detroit. The talk covers Remora’s point-source capture method, in-house manufacturing, and engine simulator for testing system performance. Gross says the company aims to scale the technology across transportation and other industries to capture up to a billion tons of CO₂ annually.

Surbhi Sarna describes how a personal health scare led her to found InVision Medical, which developed a device to collect cells from the fallopian tube for cancer evaluation. She explains how she validated the concept by speaking with physicians, raised seed funding after repeated investor rejections, and built the product through clinical studies to FDA clearance. Boston Scientific acquired InVision Medical for $275 million, securing the product’s future. Sarna closes with lessons about persistence, finding supportive people, and judging founders by the problem they are solving rather than their degrees.